| 417716-92-8 Basic information More.. |
Product Name: | Lenvatinib | Synonyms: | 4-[3-Chloro-4-(cyclopropylaminocarbonyl)aminophenoxy]-7-methoxy-6-quinolinecarboxamide;E7080 (Lenvatinib);ER-203492-00;1-(4-(6-carbamoyl-7-methoxyquinolin-4-yloxy)-2-chlorophenyl)-3-cyclopropylurea;4-[3-Chloro-4-(cyclopropylaminocarbonyl)aminophenoxy]-7-methoxy-6-quinolinecarboxamide XEN445;E70801-(4-(6-carbamoyl-7-methoxyquinolin-4-yloxy)-2-chlorophenyl)-3-cyclopropylurea;4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide methanesulfonate;LENVATINIB | CAS: | 417716-92-8 | MF: | C21H19ClN4O4 | MW: | 426.85 | EINECS: | 1592732-453-0 | Mol File: | 417716-92-8.mol | |
Use
Lenvatinib is used to treat a certain type of thyroid cancer that has returned or that has spread to other parts of the body and cannot be treated with radioactive iodine.
- Lenvatinib
-
- US $100.00-95.00 / kg
- 2024-04-30
- CAS:417716-92-8
- Min. Order: 1kg
- Purity: 99.99%
- Supply Ability: 100Tons
- Lenvatinib
-
- US $8905.00-8200.00 / kg
- 2024-04-30
- CAS:417716-92-8
- Min. Order: 1kg
- Purity: 99%
- Supply Ability: 5000
- Lenvatinib
-
- US $60.00-600.00 / kg
- 2024-01-02
- CAS:417716-92-8
- Min. Order: 10kg
- Purity: 0.99
- Supply Ability: 20tons
|
417716-92-8
Recommend Suppliers |
|